Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Cervical Cancer, February 2021

Free Subscription


Abstracts

Retrieve all available abstracts of the following 263 articles:
HTML format


 

Single Articles

  1. JAIN V, Debnath S, Rawal S
    Salvage robotic anterior pelvic exenteration for cervical cancer: technique and feasibility.
    J Robot Surg. 2021 Jan 29. pii: 10.1007/s11701-021-01195.
    PubMed    
    Abstract available

  2. KILLOCK D
    SCRT for early stage cervical cancer.
    Nat Rev Clin Oncol. 2021 Jan 29. pii: 10.1038/s41571-021-00480.
    PubMed    


  3. MANI VM, Soundari AJPG, Balasubramanian B, Park S, et al
    Evaluation of Dimer of Epicatechin from an Endophytic Fungus Curvularia australiensis FC2AP on Acute Toxicity Levels, Anti-Inflammatory and Anti-Cervical Cancer Activity in Animal Models.
    Molecules. 2021;26.
    PubMed    
    Abstract available

  4. PRIMO WQSP, Speck NMG, Roteli-Martins CM, Fernandes CE, et al
    Call to Eliminate Cervical Cancer in the Next Decade with a Focus on Brazil.
    Rev Bras Ginecol Obstet. 2021;43:1-2.
    PubMed    


  5. HOPPENOT C, Littell RD, DeEulis T, Hartenbach EM, et al
    Top Ten Tips Palliative Care Clinicians Should Know About Caring for Patients with Cervical Cancer.
    J Palliat Med. 2021 Jan 29. doi: 10.1089/jpm.2021.0006.
    PubMed    
    Abstract available

  6. GHIMIRE B, Pathak P
    Determinants of Uptake of Cervical Cancer Screening among Women Attending Tertiary Level Hospital.
    J Nepal Health Res Counc. 2021;18:649-654.
    PubMed    
    Abstract available

  7. HEIDARI SARVESTANI M, Khani Jeihooni A, Moradi Z, Dehghan A, et al
    Evaluating the effect of an educational program on increasing cervical cancer screening behavior among women in Fasa, Iran.
    BMC Womens Health. 2021;21:41.
    PubMed    
    Abstract available

  8. MILLER MJ, Xu L, Qin J, Hahn EE, et al
    Impact of COVID-19 on Cervical Cancer Screening Rates Among Women Aged 21-65 Years in a Large Integrated Health Care System - Southern California, January 1-September 30, 2019, and January 1-September 30, 2020.
    MMWR Morb Mortal Wkly Rep. 2021;70:109-113.
    PubMed    
    Abstract available

  9. BUNKARN O, Kusol K
    The Relationship between Perceived Self-Efficacy and Cervical Cancer Screening among Village Health Volunteers in Suratthani Province, Thailand.
    Asian Pac J Cancer Prev. 2021;22:179-183.
    PubMed    
    Abstract available

  10. CAMPOS LS, Limberger LF, Stein AT, Caldas JM, et al
    Survival after Laparoscopic versus Abdominal Radical Hysterectomy in Early Cervical Cancer: A Randomized Controlled Trial.
    Asian Pac J Cancer Prev. 2021;22:93-97.
    PubMed    
    Abstract available

  11. SAADI AA
    Development and Validation of Questionnaire to Assess Knowledge about Cervical Cancer among Women Aged 20 to 65 years in Oman.
    Asian Pac J Cancer Prev. 2021;22:69-74.
    PubMed    
    Abstract available

  12. PLOYSAWANG P, Rojanamatin J, Prapakorn S, Jamsri P, et al
    National Cervical Cancer Screening in Thailand.
    Asian Pac J Cancer Prev. 2021;22:25-30.
    PubMed    
    Abstract available

  13. AKILLI H, Tohma YA, Gunakan E, Kucukyildiz I, et al
    Factors affecting parametrial involvement in cervical cancer patients with tumor size
    J Turk Ger Gynecol Assoc. 2021 Jan 28. doi: 10.4274/jtgga.galenos.2020.2020.0153
    PubMed    
    Abstract available

  14. XU C, Yu Y, Li X, Sun H, et al
    Value of integrated PET-IVIM MRI in predicting lymphovascular space invasion in cervical cancer without lymphatic metastasis.
    Eur J Nucl Med Mol Imaging. 2021 Jan 27. pii: 10.1007/s00259-021-05208.
    PubMed    
    Abstract available

  15. SUN N, Zhang W, Liu J, Yang X, et al
    Propofol Inhibits the Progression of Cervical Cancer by Regulating HOTAIR/miR-129-5p/RPL14 Axis.
    Onco Targets Ther. 2021;14:551-564.
    PubMed    
    Abstract available

  16. HA JH, Kim YJ
    Photodynamic and Cold Atmospheric Plasma Combination Therapy Using Polymeric Nanoparticles for the Synergistic Treatment of Cervical Cancer.
    Int J Mol Sci. 2021;22.
    PubMed    
    Abstract available

  17. ANNIE LEUNG SO, Feldman S, Kalyanaraman R, Shanmugam V, et al
    Triaging abnormal cervical cancer screening tests using p16INK4a detection by ELISA on fresh cervical samples.
    Am J Reprod Immunol. 2021 Jan 27:e13394. doi: 10.1111/aji.13394.
    PubMed    
    Abstract available

  18. DONG H, Song J
    miR-142-3p reduces the viability of human cervical cancer cells by negatively regulating the cytoplasmic localization of HMGB1.
    Exp Ther Med. 2021;21:212.
    PubMed    
    Abstract available

  19. SHRESTHA AD, Neupane D, Ghimire S, Campbell C, et al
    Community-based intervention for cervical cancer screening uptake in a semi-urban area of Pokhara Metropolitan, Nepal (COBIN-C): study protocol for a cluster-randomized controlled trial.
    Trials. 2021;22:94.
    PubMed    
    Abstract available

  20. TORRES-ROMAN JS, Ronceros-Cardenas L, Valcarcel B, Arce-Huamani MA, et al
    Cervical cancer mortality in Peru: regional trend analysis from 2008-2017.
    BMC Public Health. 2021;21:219.
    PubMed    
    Abstract available

  21. FRANCIES FZ, Bassa S, Chatziioannou A, Kaufmann AM, et al
    Splicing Genomics Events in Cervical Cancer: Insights for Phenotypic Stratification and Biomarker Potency.
    Genes (Basel). 2021;12.
    PubMed    
    Abstract available

  22. RAMOS-PIBERNUS A, Carminelli-Corretjer P, Bermonti-Perez M, Tollinchi-Natali N, et al
    Examining Cervical Cancer Preventive Behaviors for Latinx Transmasculine Individuals among Medical Students.
    Int J Environ Res Public Health. 2021;18.
    PubMed    
    Abstract available

  23. LIU Y, Huang S, Ming X, Jing H, et al
    Surgical Approach and Use of Uterine Manipulator are not associated with LVSI in Surgery for Early-Stage Cervical Cancer.
    J Minim Invasive Gynecol. 2021 Jan 23. pii: S1553-4650(21)00046.
    PubMed    
    Abstract available

  24. BESO DELGADO M, Ibanez Cabanell J, Molina-Barcelo A, Zurriaga Llorens O, et al
    [Do women in the Valencian Community accept self-sampling as a form of cervical cancer screening?]
    Rev Esp Salud Publica. 2021;95.
    PubMed    
    Abstract available

  25. WASSIE M, Aemro A, Fentie B
    Prevalence and associated factors of baseline anemia among cervical cancer patients in Tikur Anbesa Specialized Hospital, Ethiopia.
    BMC Womens Health. 2021;21:36.
    PubMed    
    Abstract available

  26. YU DS, Song XL, Yan C
    Oncogenic miRNA-1908 targets HDAC10 and promotes the aggressive phenotype of cervical cancer cell.
    Kaohsiung J Med Sci. 2021 Jan 25. doi: 10.1002/kjm2.12348.
    PubMed    
    Abstract available

  27. VOJTISEK R, Baxa J, Kovarova P, Almortaza A, et al
    Prediction of treatment response in patients with locally advanced cervical cancer using midtreatment PET/MRI during concurrent chemoradiotherapy.
    Strahlenther Onkol. 2021 Jan 25. pii: 10.1007/s00066-020-01740.
    PubMed    
    Abstract available

  28. AUE-AUNGKUL A, Kietpeerakool C, Rattanakanokchai S, Galaal K, et al
    Postoperative interventions for preventing bladder dysfunction after radical hysterectomy in women with early-stage cervical cancer.
    Cochrane Database Syst Rev. 2021;1:CD012863.
    PubMed    
    Abstract available

  29. DAS S, Naher L, Aka TD, Aziz MA, et al
    The ECCR1 rs11615, ERCC4 rs2276466, XPC rs2228000 and XPC rs2228001 polymorphisms increase the cervical cancer risk and aggressiveness in the Bangladeshi population.
    Heliyon. 2021;7:e05919.
    PubMed    
    Abstract available

  30. WANG J, Bai Z, Gao X, Zhang N, et al
    The Effects of Age, Period, and Cohort on the Mortality of Cervical Cancer in Three High-Income Countries: Canada, Korea, and Italy.
    Biomed Res Int. 2021;2021:8829122.
    PubMed    
    Abstract available

  31. ZHANG J, He H, Wang K, Xie Y, et al
    miR-326 inhibits the cell proliferation and cancer stem cell-like property of cervical cancer in vitro and oncogenesis in vivo via targeting TCF4.
    Ann Transl Med. 2020;8:1638.
    PubMed    
    Abstract available

  32. KARCHEVA M, Yordanov A, Kostadinov S
    An overview of cervical cancer epidemiology and prevention in Bulgaria.
    Germs. 2020;10:322-327.
    PubMed    
    Abstract available

  33. PAL A, Verma P, Paul S, Majumder I, et al
    Two species of Ulva inhibits the progression of cervical cancer cells SiHa by means of autophagic cell death induction.
    3 Biotech. 2021;11:52.
    PubMed    
    Abstract available

  34. SHIBA S, Oike T, Ando K, Yoshimoto Y, et al
    Granulocyte-colony stimulating factor-producing uterine cervical cancer treated with chemoradiotherapy: A case report with mutation analysis and literature review.
    Clin Case Rep. 2020;9:185-192.
    PubMed    
    Abstract available

  35. MUNOZ-GODINEZ R, de Lourdes Mora-Garcia M, Weiss-Steider B, Montesinos-Montesinos JJ, et al
    Detection of CD39 and a Highly Glycosylated Isoform of Soluble CD73 in the Plasma of Patients with Cervical Cancer: Correlation with Disease Progression.
    Mediators Inflamm. 2020;2020:1678780.
    PubMed    
    Abstract available

  36. ZHANG C, Fu S, Wang L, Wang F, et al
    The Value and Clinical Significance of ZNF582 Gene Methylation in the Diagnosis of Cervical Cancer.
    Onco Targets Ther. 2021;14:403-411.
    PubMed    
    Abstract available

  37. SHU T, Li B, Zhao D, Wang YT, et al
    [Open nerve-plane sparing radical hysterectomy in locally advanced cervical cancer: evaluation on efficacy and long-term survival outcomes].
    Zhonghua Fu Chan Ke Za Zhi. 2021;56:43-51.
    PubMed    
    Abstract available

  38. LI J, Gao JJ, Li N, Wang YW, et al
    Distribution of human papillomavirus genotypes in western China and their association with cervical cancer and precancerous lesions.
    Arch Virol. 2021 Jan 24. pii: 10.1007/s00705-021-04960.
    PubMed    
    Abstract available

  39. RAVAIOLI S, Pirini F, Tumedei MM, Puccetti M, et al
    An initiative to assess the quality of Tanzanian cervical cancer specimens for HPV and telomerase detection.
    Pathol Res Pract. 2021;218:153344.
    PubMed    
    Abstract available

  40. YU H, Tang X, Yang X, Wen D, et al
    Dose fusion and efficacy evaluation of different radical radiotherapy doses for cervical cancer.
    Brachytherapy. 2021 Jan 20. pii: S1538-4721(20)30291.
    PubMed    
    Abstract available

  41. LIU Q, Li W, Xie M, Yang M, et al
    Development and validation of a SEER-based prognostic nomogram for cervical cancer patients below the age of 45 years.
    Bosn J Basic Med Sci. 2020 Dec 31. doi: 10.17305/bjbms.2020.5271.
    PubMed    
    Abstract available

  42. BYUN JM, Cho HJ, Park HY, Lee DS, et al
    The clinical significance of HERV-H LTR -associating 2 expression in cervical adenocarcinoma.
    Medicine (Baltimore). 2021;100:e23691.
    PubMed    
    Abstract available

  43. BALTISSER I
    [Cytological findings in glandular lesions of the uterine cervix].
    Pathologe. 2020;41.
    PubMed    
    Abstract available

  44. OCADIZ-DELGADO R, Lizcano-Meneses S, Trejo-Vazquez JA, Conde-Perezprina JC, et al
    Circulating miR-15b, miR-34a and miR-218 as promising novel early low-invasive biomarkers of cervical carcinogenesis.
    APMIS. 2021;129:70-79.
    PubMed    
    Abstract available

  45. MALTA DC, Prates EJS, Silva AGD, Santos FMD, et al
    Inequalities in mammography and Papanicolaou test coverage: a time-series study.
    Sao Paulo Med J. 2020;138:475-482.
    PubMed    
    Abstract available

  46. ROSENBERG M, Amisi JA, Szkwarko D, Tran DN, et al
    The relationship between a microfinance-based healthcare delivery platform, health insurance coverage, health screenings, and disease management in rural Western Kenya.
    BMC Health Serv Res. 2020;20:868.
    PubMed    
    Abstract available

  47. WHITE CM, Bakhiet S, Bates M, Ruttle C, et al
    Exposure to tobacco smoke measured by urinary nicotine metabolites increases risk of p16/Ki-67 co-expression and high-grade cervical neoplasia in HPV positive women: A two year prospective study.
    Cancer Epidemiol. 2020;68:101793.
    PubMed    
    Abstract available

  48. AN J, Lei H, Xie X, Sun P, et al
    An Abnormal Precone Endocervical Curettage Result Is an Independent Risk Factor for Positive Margins in Conization Specimens.
    Oncol Res Treat. 2020;43:518-525.
    PubMed    
    Abstract available

  49. DILLNER J, Nygard M, Munk C, Hortlund M, et al
    Authors' reply.
    Vaccine. 2020;38:5741.
    PubMed    


  50. SASIENI P, Castanon A
    Evidence of HPV vaccination efficacy comes from more than clinical trials.
    Vaccine. 2020 Jul 9. pii: S0264-410X(20)30883.
    PubMed    


  51. YAMADA I, Oshima N, Wakana K, Miyasaka N, et al
    Uterine Cervical Carcinoma: Evaluation Using Non-Gaussian Diffusion Kurtosis Imaging and Its Correlation With Histopathological Findings.
    J Comput Assist Tomogr. 2021;45:29-36.
    PubMed    
    Abstract available

  52. YU L, Zhang JF, Li M, Jiang D, et al
    Combining viscosity-restricted intramolecular motion and mitochondrial targeting leads to selective tumor visualization.
    Chem Commun (Camb). 2020;56:6684-6687.
    PubMed    
    Abstract available

  53. ATALLAH S, Barbera L, Folwell M, Howell D, et al
    Feasibility of implementing a cervix cancer-specific patient-reported outcome measure in routine ambulatory clinics.
    Support Care Cancer. 2021;29:499-507.
    PubMed    
    Abstract available

  54. CARRASQUILLO O, Seay J, Jhaveri V, Long T, et al
    Increasing uptake of evidence-based screening services though a community health worker-delivered multimodality program: study protocol for a randomized pragmatic trial.
    Trials. 2020;21:368.
    PubMed    
    Abstract available

  55. QI T, Song C, He J, Shen W, et al
    Highly Sensitive Detection of Multiple MicroRNAs by High-Performance Liquid Chromatography Coupled with Long and Short Probe-Based Recycling Amplification.
    Anal Chem. 2020;92:5033-5040.
    PubMed    
    Abstract available

  56. LI Y, Ding Y, Ding N, Zhang H, et al
    MicroRNA-625-5p Sponges lncRNA MALAT1 to Inhibit Cervical Carcinoma Cell Growth by Suppressing NF-kappaB Signaling.
    Cell Biochem Biophys. 2020;78:217-225.
    PubMed    
    Abstract available

  57. VON LINSINGEN R, Pinho de Franca P, de Carvalho NS, Bicalho MDG, et al
    MICA and KLRK1 genes and their impact in cervical intraepithelial neoplasia development in the southern Brazilian population.
    Hum Immunol. 2020;81:249-253.
    PubMed    
    Abstract available

  58. HIRAI Y, Domae E, Yoshikawa Y, Tomonaga K, et al
    Differential roles of two DDX17 isoforms in the formation of membraneless organelles.
    J Biochem. 2020;168:33-40.
    PubMed    
    Abstract available

  59. MASSAD LS, Xie X, Minkoff H, Kassaye S, et al
    Longitudinal assessment of abnormal Papanicolaou test rates among women with HIV.
    AIDS. 2020;34:73-80.
    PubMed    
    Abstract available

  60. TOLIMAN PJ, Phillips S, de Jong S, O'Neill T, et al
    Evaluation of p16/Ki-67 dual-stain cytology performed on self-collected vaginal and clinician-collected cervical specimens for the detection of cervical pre-cancer.
    Clin Microbiol Infect. 2020;26:748-752.
    PubMed    
    Abstract available

  61. VAN DE WIJGERT JHHM, Gill AC, Chikandiwa A, Verwijs MC, et al
    Human papillomavirus infection and cervical dysplasia in HIV-positive women: potential role of the vaginal microbiota.
    AIDS. 2019 Sep 26. doi: 10.1097/QAD.0000000000002381.
    PubMed    
    Abstract available

  62. VAN DEN HEUVEL CNAM, Loopik DL, Ebisch RMF, Elmelik D, et al
    RNA-based high-risk HPV genotyping and identification of high-risk HPV transcriptional activity in cervical tissues.
    Mod Pathol. 2020;33:748-757.
    PubMed    
    Abstract available

  63. LIU N, Yan L, Shan F, Wang X, et al
    Low-dose naltrexone plays antineoplastic role in cervical cancer progression through suppressing PI3K/AKT/mTOR pathway.
    Transl Oncol. 2021;14:101028.
    PubMed    
    Abstract available

  64. LEE N, Mun J, Park SJ, Lee EJ, et al
    Vaginal delivery after robot-assisted uterine artery-preserving radical trachelectomy for early-stage cervical cancer.
    Obstet Gynecol Sci. 2021 Feb 4. pii: ogs.19127. doi: 10.5468/ogs.19127.
    PubMed    
    Abstract available

  65. ZAMULAEVA I, Selivanova E, Matchuk O, Kiseleva V, et al
    Radiation Response of Cervical Cancer Stem Cells Is Associated with Pretreatment Proportion of These Cells and Physical Status of HPV DNA.
    Int J Mol Sci. 2021;22.
    PubMed    
    Abstract available

  66. GUO FF, Zhao RJ, Li DJ, Xu ZG, et al
    [Role of up-regulated DDX3 in the proliferation of human cervical cancer cells].
    Zhonghua Bing Li Xue Za Zhi. 2021;50:119-124.
    PubMed    
    Abstract available

  67. BASU P, Wu P, Li C, Ye DM, et al
    Circular RNA circEPSTI1 accelerates cervical cancer progression via miR-375/409-3P/515-5p-SLC7A11 axis.
    Aging (Albany NY). 2021;13.
    PubMed    
    Abstract available

  68. OTANI Y, Ohno T, Ando K, Murata K, et al
    Dosimetric feasibility of computed tomography-based image-guided brachytherapy in locally advanced cervical cancer: a Japanese prospective multi-institutional study.
    J Radiat Res. 2021 Feb 3. pii: 6126961. doi: 10.1093.
    PubMed    
    Abstract available

  69. HERNANDEZ VARGAS JA, Ramirez Barbosa PX, Valbuena-Garcia AM, Acuna L, et al
    Factors associated with delays in time to treatment initiation in Colombian women with cervical cancer: A cross-sectional analysis.
    Gynecol Oncol Rep. 2021;35:100697.
    PubMed    
    Abstract available

  70. LIU CH, Huang ZH, Dong XY, Zhang XQ, et al
    Corrigendum to "Inhibition of Uncoupling Protein 2 Enhances the Radiosensitivity of Cervical Cancer Cells by Promoting the Production of Reactive Oxygen Species".
    Oxid Med Cell Longev. 2021;2021:1841783.
    PubMed    
    Abstract available

  71. PARK SH, Lim H, Bae BK, Hahm MH, et al
    Robustness of magnetic resonance radiomic features to pixel size resampling and interpolation in patients with cervical cancer.
    Cancer Imaging. 2021;21:19.
    PubMed    
    Abstract available

  72. BURT LM, McCormak M, Lecuru F, Kanyike DM, et al
    Cervix Cancer in Sub-Saharan Africa: An Assessment of Cervical Cancer Management.
    JCO Glob Oncol. 2021;7:173-182.
    PubMed    
    Abstract available

  73. BORRULL-GUARDENO J, Sebastia-Laguarda C, Donat-Colomer F, Sanchez-Martinez V, et al
    Women's knowledge and attitudes towards cervical cancer prevention: A qualitative study in the Spanish context.
    J Clin Nurs. 2021 Feb 2. doi: 10.1111/jocn.15687.
    PubMed    
    Abstract available

  74. LI XR, Jin JJ, Yu Y, Wang XH, et al
    PET-CT radiomics by integrating primary tumor and peritumoral areas predicts E-cadherin expression and correlates with pelvic lymph node metastasis in early-stage cervical cancer.
    Eur Radiol. 2021 Feb 2. pii: 10.1007/s00330-021-07690.
    PubMed    
    Abstract available

  75. CHEN C, Guo J, Liu P, Li Z, et al
    Comparison of survival outcomes between laparoscopic surgery and abdominal surgery for radical hysterectomy as primary treatment in patients with stage IB2/IIA2 cervical cancer.
    J Obstet Gynaecol Res. 2021 Feb 1. doi: 10.1111/jog.14693.
    PubMed    
    Abstract available

  76. KIM SI, Lee J, Hong J, Lee SJ, et al
    Comparison of abdominal and minimally invasive radical hysterectomy in patients with early stage cervical cancer.
    Int J Med Sci. 2021;18:1312-1317.
    PubMed    
    Abstract available

  77. GABRICHIDZE T, Mchedlishvili I, Zhizhilashvili A, Gamkrelidze A, et al
    TEMPORAL TRENDS OF CERVICAL CANCER MORTALITY IN GEORGIA, 2011-2018.
    Georgian Med News. 2020;:17-21.
    PubMed    
    Abstract available

  78. DINIZ TP, Faloppa CC, Mantoan H, Goncalves BT, et al
    Pathological factors associated with non-sentinel lymph node metastasis in early stage cervical cancer.
    J Surg Oncol. 2021 Feb 1. doi: 10.1002/jso.26341.
    PubMed    
    Abstract available


  79. Erratum to: A multi-institutional survey of the quality of life after treatment for uterine cervical cancer: a comparison between radical radiotherapy and surgery in Japan.
    J Radiat Res. 2021 Feb 2. pii: 6125901. doi: 10.1093.
    PubMed    


  80. JIANG J, Gao L, Lan Y, Wang Y, et al
    TIPE1 Promotes Cervical Cancer Cell Chemoresistance to Cisplatin in a Wild-Type p53-Dependent Manner.
    Front Oncol. 2021;10:593615.
    PubMed    
    Abstract available

  81. HASHMI AA, Naz S, Ahmed O, Yaqeen SR, et al
    Comparison of Liquid-Based Cytology and Conventional Papanicolaou Smear for Cervical Cancer Screening: An Experience From Pakistan.
    Cureus. 2020;12:e12293.
    PubMed    
    Abstract available

  82. ZELEKE S, Anley M, Kefale D, Wassihun B, et al
    Factors Associated with Delayed Diagnosis of Cervical Cancer in Tikur Anbesa Specialized Hospital, Ethiopia, 2019: Cross-Sectional Study.
    Cancer Manag Res. 2021;13:579-585.
    PubMed    
    Abstract available

  83. HOLT HK, Zhang X, Hu SY, Zhao FH, et al
    Inequalities in Cervical Cancer Screening Uptake Between Chinese Migrant Women and Local Women: A Cross-Sectional Study.
    Cancer Control. 2021;28:1073274820985792.
    PubMed    
    Abstract available

  84. ZHOU M, Yang Z, Wang D, Chen P, et al
    The circular RNA circZFR phosphorylates Rb promoting cervical cancer progression by regulating the SSBP1/CDK2/cyclin E1 complex.
    J Exp Clin Cancer Res. 2021;40:48.
    PubMed    
    Abstract available

  85. YOON D, Lee JH, Lee H, Shin JY, et al
    Association between human papillomavirus vaccination and serious adverse events in South Korean adolescent girls: nationwide cohort study.
    BMJ. 2021;372:m4931.
    PubMed    
    Abstract available

  86. GEYANG D, Gaowen C, Xiaoxuan LI, Youhong Z, et al
    [Pregnancy-preserving and maternal-fetal management in a patient with rare large cell neuroendocrine carcinoma of the uterine cervix].
    Nan Fang Yi Ke Da Xue Xue Bao. 2021;41:1-9.
    PubMed    
    Abstract available

  87. ZHAI Q, Ren T, Fu Y, Zhang Z, et al
    [Characteristics of cervical microecology in late reproductive-age women with different grades of cervical lesions].
    Nan Fang Yi Ke Da Xue Xue Bao. 2020;40:1768-1775.
    PubMed    
    Abstract available

  88. LIU Y, Wang Y, Shen X, Chen C, et al
    Down-regulation of lncRNA PCGEM1 inhibits cervical carcinoma by modulating the miR-642a-5p/LGMN axis.
    Exp Mol Pathol. 2020;117:104561.
    PubMed    
    Abstract available

  89. WAROWICKA A, Wolun-Cholewa M, Kwasniewska A, Gozdzicka-Jozefiak A, et al
    Alternations in mitochondrial genome in carcinogenesis of HPV positive cervix.
    Exp Mol Pathol. 2020;117:104530.
    PubMed    
    Abstract available

  90. JOHARINIA N, Faghihinejad S, Seyedi K, Farhadi A, et al
    Co-existing of HSV1/2 or EBV Infection with the Presence of High-Risk HPV DNA in Cervical Lesions in the Southwest of Iran.
    Asian Pac J Cancer Prev. 2020;21:1459-1464.
    PubMed    
    Abstract available

  91. NAPITUPULU D, Puspitaningtyas H, Mualim K, Kusumanto A, et al
    Factors that Affected Women Undergoing Cryotherapy Following Cancer Screening with Visual Inspection of the Cervix Using Acetic Acid Method.
    Asian Pac J Cancer Prev. 2020;21:1423-1429.
    PubMed    
    Abstract available

  92. BANERJEE D, Mandal R, Mandal A, Ghosh I, et al
    A Prospective Randomized Trial to Compare Safety, Acceptability and Efficacy of Thermal Ablation and Cryotherapy in a Screen and Treat Setting.
    Asian Pac J Cancer Prev. 2020;21:1391-1398.
    PubMed    
    Abstract available

  93. RAFFLE AE, Gray JAM
    The 1960s cervical screening incident at National Women's Hospital, Auckland, New Zealand: insights for screening research, policy making, and practice.
    J Clin Epidemiol. 2020;122:A8-A13.
    PubMed    
    Abstract available

  94. ZONG L, Zhang Q, Zhou Y, Kong Y, et al
    Expression and Significance of Immune Checkpoints in Clear Cell Carcinoma of the Uterine Cervix.
    J Immunol Res. 2020;2020:1283632.
    PubMed    
    Abstract available

  95. CELEWICZ A, Celewicz M, Michalczyk M, Rzepka R, et al
    Perspectives in HPV Secondary Screening and Personalized Therapy Basing on Our Understanding of HPV-Related Carcinogenesis Pathways.
    Mediators Inflamm. 2020;2020:2607594.
    PubMed    
    Abstract available

  96. DE CARVALHO SH, Rosa DAN, Santos ALF, de Medeiros APP, et al
    Description of Referrals for Colposcopy in a Hospital in Brazil.
    Rev Bras Ginecol Obstet. 2020;42:140-145.
    PubMed    
    Abstract available

  97. LING W, Yangchun X, Wei W, Qiang W, et al
    Knockdown of long non-coding RNA GHET1 suppresses cervical carcinoma in vitro and in vivo.
    Cancer Biomark. 2020;28:21-32.
    PubMed    
    Abstract available

  98. TASAKA N, Minaguchi T, Hosokawa Y, Takao W, et al
    Prevalence of venous thromboembolism at pretreatment screening and associated risk factors in 2086 patients with gynecological cancer.
    J Obstet Gynaecol Res. 2020;46:765-773.
    PubMed    
    Abstract available

  99. MALONE C, Barnabas RV, Buist DSM, Tiro JA, et al
    Cost-effectiveness studies of HPV self-sampling: A systematic review.
    Prev Med. 2020;132:105953.
    PubMed    
    Abstract available

  100. LIANG BQ, Zhou SG, Liu JH, Huang YM, et al
    Clinicopathologic features and outcome of cervical cancer: implications for treatment.
    Eur Rev Med Pharmacol Sci. 2021;25:696-709.
    PubMed    
    Abstract available

  101. TIAN L, Han F, Yang J, Ming X, et al
    Long noncoding RNA LINC01006 exhibits oncogenic properties in cervical cancer by functioning as a molecular sponge for microRNA285p and increasing PAK2 expression.
    Int J Mol Med. 2021;47.
    PubMed    
    Abstract available

  102. SCHARL S, Becher C, Gerken M, Scharl A, et al
    Is there a benefit for adjuvant radio(chemo)therapy in early cervical cancer? Results from a population-based study.
    Arch Gynecol Obstet. 2021 Feb 11. pii: 10.1007/s00404-021-05989.
    PubMed    
    Abstract available

  103. AL-OQAIL MM, Farshori NN, Al-Sheddi ES, Al-Massarani SM, et al
    Oxidative Stress Mediated Cytotoxicity, Cell Cycle Arrest, and Apoptosis Induced by Rosa damascena in Human Cervical Cancer HeLa Cells.
    Oxid Med Cell Longev. 2021;2021:6695634.
    PubMed    
    Abstract available

  104. LU D, Qian J, Li W, Feng Q, et al
    Erratum: beta-Hydroxyisovaleryl-shikonin induces human cervical cancer cell apoptosis via PI3K/AKT/mTOR signaling.
    Oncol Lett. 2021;21:195.
    PubMed    
    Abstract available

  105. LI Y, Kou J, Wu T, Zheng P, et al
    Screening of Therapeutic Candidate Genes of Quercetin for Cervical Cancer and Analysis of Their Regulatory Network.
    Onco Targets Ther. 2021;14:857-866.
    PubMed    
    Abstract available

  106. HUO X, Zhou X, Peng P, Yu M, et al
    Identification of a Six-Gene Signature for Predicting the Overall Survival of Cervical Cancer Patients.
    Onco Targets Ther. 2021;14:809-822.
    PubMed    
    Abstract available

  107. CHIBONDA S, Ndlovu N, Tsikai N, Munangaidzwa L, et al
    Correction to: High dose rate intra-cavitary brachytherapy with cobalt 60 source for locally advanced cervical cancer: the Zimbabwean experience.
    Infect Agent Cancer. 2021;16:12.
    PubMed    


  108. KHAN I, Zaib S, Javed M, Rashid F, et al
    Antiproliferative and Pro-Apoptotic Effects of Thiazolo[3,2-b][1,2,4]triazoles in Breast and Cervical Cancer Cells.
    Anticancer Agents Med Chem. 2021 Jan 25. pii: ACAMC-EPUB-113649.
    PubMed    
    Abstract available

  109. TSUYOSHI H, Tsujikawa T, Yamada S, Okazawa H, et al
    Diagnostic Value of (18)F-FDG PET/MRI for Revised 2018 FIGO Staging in Patients with Cervical Cancer.
    Diagnostics (Basel). 2021;11.
    PubMed    
    Abstract available

  110. ESFANDYARI YB, Doustvandi MA, Amini M, Baradaran B, et al
    MicroRNA-143 Sensitizes Cervical Cancer Cells to Cisplatin: a Promising Anticancer Combination Therapy.
    Reprod Sci. 2021 Feb 10. pii: 10.1007/s43032-021-00479.
    PubMed    
    Abstract available

  111. NIE J, Wu Q, Yan A, Wu Z, et al
    Impact of different therapies on the survival of patients with stage I-IIA cervical cancer with intermediate risk factors.
    Ann Transl Med. 2021;9:142.
    PubMed    
    Abstract available

  112. ZOU T, Gao Y, Qie M
    MiR-29c-3p inhibits epithelial-mesenchymal transition to inhibit the proliferation, invasion and metastasis of cervical cancer cells by targeting SPARC.
    Ann Transl Med. 2021;9:125.
    PubMed    
    Abstract available

  113. DERBIE A, Mekonnen D, Misgan E, Alemu YM, et al
    Low level of knowledge about cervical cancer among Ethiopian women: a systematic review and meta-analysis.
    Infect Agent Cancer. 2021;16:11.
    PubMed    
    Abstract available

  114. SIDDIQUI S, Zia Q, Abbas M, Verma S, et al
    Antiproliferative Activity of Cissus quadrangularis L. Extract against Human Cervical Cancer Cells: In Vitro and In Silico Analysis.
    Anticancer Agents Med Chem. 2021 Feb 9. pii: ACAMC-EPUB-114069.
    PubMed    
    Abstract available

  115. MONGIA A, Pompeo G, Sani C, Burroni E, et al
    Hybrid capture 2 and cobas(R) 4800: Comparison of performance of two clinically validated tests for human papillomavirus primary screening of cervical cancer.
    J Med Screen. 2021 Feb 10:969141321992820. doi: 10.1177/0969141321992820.
    PubMed    
    Abstract available

  116. BAIOCCHI G, Diniz TP, Bovolim G, Goncalves BT, et al
    Predictive Factors for Residual Disease After Conization in Cervical Cancer.
    Ann Surg Oncol. 2021 Feb 10. pii: 10.1245/s10434-021-09656.
    PubMed    
    Abstract available

  117. BAIOCCHI G, Diniz TP, Bovolim G, De Brot L, et al
    ASO Author Reflections: Is Residual Disease Predictable After Conization in Cervical Cancer?
    Ann Surg Oncol. 2021 Feb 10. pii: 10.1245/s10434-021-09678.
    PubMed    


  118. BHAT S, Kabekkodu SP, Adiga D, Fernandes R, et al
    ZNF471 modulates EMT and functions as methylation regulated tumor suppressor with diagnostic and prognostic significance in cervical cancer.
    Cell Biol Toxicol. 2021 Feb 10. pii: 10.1007/s10565-021-09582.
    PubMed    
    Abstract available

  119. GRIESEL M, Seraphin TP, Mezger NC, Hammerl L, et al
    Cervical cancer in Sub-Saharan Africa: a multinational population-based cohort study on patterns and guideline adherence of care.
    Oncologist. 2021 Feb 10. doi: 10.1002/onco.13718.
    PubMed    
    Abstract available

  120. SEHNAL B, Slama J
    What next in cervical cancer screening?
    Ceska Gynekol. 2020;85:236-243.
    PubMed    
    Abstract available

  121. KRIVUS S, Kudela E, Mersakova S, Holubekova V, et al
    Circulating HPV DNA in patients with cervical precancerous lesions and cervical cancer.
    Ceska Gynekol. 2020;85:214-219.
    PubMed    
    Abstract available

  122. SATO F, Bhawal UK, Sugiyama N, Osaki S, et al
    Potential Role of DEC1 in Cervical Cancer Cells Involving Overexpression and Apoptosis.
    Clocks Sleep. 2020;2:26-38.
    PubMed    
    Abstract available

  123. MATTICK LJ, Ochs-Balcom HM, Mwaiselage J, Kahesa C, et al
    Downstaging of cervical cancer in Tanzania over a 16-year period.
    Cancer Causes Control. 2021 Feb 9. pii: 10.1007/s10552-021-01397.
    PubMed    
    Abstract available

  124. KONO K, Morisada T, Saika K, Aoki ES, et al
    The first-round results of a population-based cohort study of HPV testing in Japanese cervical cancer screening: baseline characteristics, screening results, and referral rate.
    J Gynecol Oncol. 2021 Jan 26:e29. doi: 10.3802/jgo.2021.
    PubMed    
    Abstract available

  125. ZHONG Q, Lu M, Yuan W, Cui Y, et al
    Eight-lncRNA signature of cervical cancer were identified by integrating DNA methylation, copy number variation and transcriptome data.
    J Transl Med. 2021;19:58.
    PubMed    
    Abstract available

  126. LIU H, Song M, Sun X, Zhang X, et al
    T-box transcription factor TBX1, targeted by microRNA-6727-5p, inhibits cell growth and enhances cisplatin chemosensitivity of cervical cancer cells through AKT and MAPK pathways.
    Bioengineered. 2021;12:565-577.
    PubMed    
    Abstract available

  127. TAMBAS M, Tavli B, Bilici N, Dizman A, et al
    Computed Tomography-guided Optimization of Needle Insertion For Combined Intracavitary/Interstitial Brachytherapy With Utrecht Applicator in Locally Advanced Cervical Cancer.
    Pract Radiat Oncol. 2021 Feb 5. pii: S1879-8500(21)00043.
    PubMed    
    Abstract available

  128. RYZHOV A, Corbex M, Pineros M, Barchuk A, et al
    Comparison of breast cancer and cervical cancer stage distributions in ten newly independent states of the former Soviet Union: a population-based study.
    Lancet Oncol. 2021 Feb 5. pii: S1470-2045(20)30674.
    PubMed    
    Abstract available

  129. TOMAO F, Caruso G, Musacchio L, Di Donato V, et al
    Capecitabine in treating patients with advanced, persistent, or recurrent cervical cancer: an active and safe option?
    Expert Opin Drug Saf. 2021 Feb 8. doi: 10.1080/14740338.2021.1887850.
    PubMed    
    Abstract available

  130. PHOOLCHAROEN N, Kremzier M, Eaton V, Sarchet V, et al
    American Society of Clinical Oncology (ASCO) Cervical Cancer Prevention Program: A Hands-On Training Course in Nepal.
    JCO Glob Oncol. 2021;7:204-209.
    PubMed    
    Abstract available

  131. BEHBOODI N, Farazestanian M, Rastgar-Moghadam A, Mehramiz M, et al
    Association of a variant in the tumor necrosis factor alpha gene with risk of cervical cancer.
    Mol Biol Rep. 2021 Feb 8. pii: 10.1007/s11033-021-06185.
    PubMed    
    Abstract available

  132. SHENDGE AK, Panja S, Mandal N
    Tropical lichen, Dirinaria consimilis, induces ROS-mediated activation of MAPKs and triggers caspase cascade mediated apoptosis in brain and cervical cancer cells.
    Mol Cell Biochem. 2021 Feb 8. pii: 10.1007/s11010-021-04087.
    PubMed    
    Abstract available

  133. XU F, Shen J, Xu S
    Integrated Bioinformatical Analysis Identifies GIMAP4 as an Immune-Related Prognostic Biomarker Associated With Remodeling in Cervical Cancer Tumor Microenvironment.
    Front Cell Dev Biol. 2021;9:637400.
    PubMed    
    Abstract available

  134. ZHANG Y, Sun D, Song J, Yang N, et al
    Integrated Profiles Analysis Identified a Coding-Non-Coding Signature for Predicting Lymph Node Metastasis and Prognosis in Cervical Cancer.
    Front Cell Dev Biol. 2021;8:631491.
    PubMed    
    Abstract available

  135. MORENO-ACOSTA P, Romero-Rojas A, Vial N, Huertas A, et al
    Persistent High-Risk HPV Infection and Molecular Changes Related to the Development of Cervical Cancer.
    Case Rep Obstet Gynecol. 2020;2020:6806857.
    PubMed    
    Abstract available

  136. LU W, Lu C, Yu Z, Gao L, et al
    Chemoradiotherapy alone vs. chemoradiotherapy and hysterectomy for locally advanced cervical cancer: A systematic review and updated meta-analysis.
    Oncol Lett. 2021;21:160.
    PubMed    
    Abstract available

  137. SHIMOMURA M, Fukuda T, Awazu Y, Nanno S, et al
    PRMT1 expression predicts response to neoadjuvant chemotherapy for locally advanced uterine cervical cancer.
    Oncol Lett. 2021;21:150.
    PubMed    
    Abstract available

  138. DING XZ, Zhang SQ, Deng XL, Qiang JH, et al
    Serum Exosomal lncRNA DLX6-AS1 Is a Promising Biomarker for Prognosis Prediction of Cervical Cancer.
    Technol Cancer Res Treat. 2021;20:1533033821990060.
    PubMed    
    Abstract available

  139. MWAKA AD, Walter FM, Scott S, Harries J, et al
    Symptom appraisal, help-seeking and perceived barriers to healthcare seeking in Uganda: an exploratory study among women with potential symptoms of breast and cervical cancer.
    BMJ Open. 2021;11:e041365.
    PubMed    
    Abstract available

  140. PACIFICO DE CARVALHO N, Pilecco FB, Cherchiglia ML
    Regional inequalities in cervical cancer survival in Minas Gerais State, Brazil.
    Cancer Epidemiol. 2021;71.
    PubMed    
    Abstract available

  141. S S, Shukla V, Khan GN, Eswaran S, et al
    Integrated bioinformatic analysis of miR-15a/16-1 cluster network in cervical cancer.
    Reprod Biol. 2021;21:100482.
    PubMed    
    Abstract available

  142. XIAOFEI J, Mingqing S, Miao S, Yizhen Y, et al
    Oleanolic acid inhibits cervical cancer Hela cell proliferation through modulation of the ACSL4 ferroptosis signaling pathway.
    Biochem Biophys Res Commun. 2021;545:81-88.
    PubMed    
    Abstract available

  143. SAVAS LS, Atkinson JS, Figueroa-Solis E, Valdes A, et al
    A lay health worker intervention to improve breast and cervical cancer screening among Latinas in El Paso, Texas: A randomized control trial.
    Prev Med. 2021 Feb 3:106446. doi: 10.1016/j.ypmed.2021.106446.
    PubMed    
    Abstract available

  144. LIM AWW
    Will COVID-19 Be the Tipping Point for Primary HPV Self-sampling?
    Cancer Epidemiol Biomarkers Prev. 2021;30:245-247.
    PubMed    
    Abstract available

  145. GILHAM C, Crosbie EJ, Peto J
    Cervical cancer screening in older women.
    BMJ. 2021;372:n280.
    PubMed    


  146. WANG K, Jiao Z, Chen H, Liu X, et al
    The association between rs1800872 polymorphism in interleukin-10 and risk of cervical cancer: A meta-analysis.
    Medicine (Baltimore). 2021;100:e23892.
    PubMed    
    Abstract available

  147. LI W, He F, Liu P, Duan H, et al
    Uterine corpus invasion in cervical cancer: a multicenter retrospective case-control study.
    Arch Gynecol Obstet. 2021 Feb 5. pii: 10.1007/s00404-021-05968.
    PubMed    
    Abstract available

  148. BASU P, Zhang F, Shi M, Zhou CM, et al
    [Clinicopathological analysis of 6 cases of minimal deviation adenocarcinoma of cervix with 5 ovarian metastasis].
    Zhonghua Bing Li Xue Za Zhi. 2021;50:134-136.
    PubMed    


  149. FUJIWARA H, Nakashima M, Banno H, Hikami K, et al
    [A Consideration for the Surgical Approach in Laparoscopic Total Pelvic Exenteration after Radiotherapy : A Case Report].
    Hinyokika Kiyo. 2021;67:31-35.
    PubMed    
    Abstract available

  150. KOBAYASHI E, Kanao H, Takekuma M, Nishio S, et al
    A retrospective assessment of the safety and efficacy of laparoscopic radical hysterectomy in Japan during the early years following its introduction: a Japanese Gynecologic Oncology Group study (JGOG1081S).
    Int J Clin Oncol. 2021;26:417-428.
    PubMed    
    Abstract available

  151. EZEANOCHIE M, Olasimbo P
    Awareness and uptake of human papilloma virus vaccines among female secondary school students in Benin City, Nigeria.
    Afr Health Sci. 2020;20:45-50.
    PubMed    
    Abstract available

  152. TAGUCHI A, Nagasaka K, Plessy C, Nakamura H, et al
    Use of Cap Analysis Gene Expression to detect human papillomavirus promoter activity patterns at different disease stages.
    Sci Rep. 2020;10:17991.
    PubMed    
    Abstract available

  153. FANOURIAKIS A, Tziolos N, Bertsias G, Boumpas DT, et al
    Update omicronn the diagnosis and management of systemic lupus erythematosus.
    Ann Rheum Dis. 2021;80:14-25.
    PubMed    
    Abstract available

  154. MONICA, Mishra R
    An epidemiological study of cervical and breast screening in India: district-level analysis.
    BMC Womens Health. 2020;20:225.
    PubMed    
    Abstract available

  155. ROMERO DE MELLO SA SA, Mramba LK, Sattari M
    Improving Preventive Care for Women through a Provider Reminder Tool.
    South Med J. 2020;113:475-481.
    PubMed    
    Abstract available

  156. BRUNNHOELZL D, Hanania AN, Echeverria A, Sunde J, et al
    Paracervical blocks facilitate timely brachytherapy amidst COVID-19.
    Brachytherapy. 2021;20:284-289.
    PubMed    
    Abstract available

  157. LI Y
    MIR31HG exhibits oncogenic property and acts as a sponge for miR-361-3p in cervical carcinoma.
    Biochem Biophys Res Commun. 2020;529:890-897.
    PubMed    
    Abstract available

  158. NAKAMURA T, Yoshihara M, Tamauchi S, Kajiyama H, et al
    Follicular dendritic cell sarcoma of the uterine cervix: a case report.
    BMC Womens Health. 2020;20:182.
    PubMed    
    Abstract available

  159. VAN MULDERS S, Faes E, Broeckx G, Jacquemyn Y, et al
    Cervicovaginal cellular angiofibroma.
    BMJ Case Rep. 2020;13.
    PubMed    
    Abstract available

  160. KOTAKE Y, Tsuruda T
    Long Noncoding RNA ANROC on the INK4 Locus Functions to Suppress Cell Proliferation.
    Cancer Genomics Proteomics. 2020;17:425-430.
    PubMed    
    Abstract available

  161. MOHAN G, Chattopadhyay S
    Cost-effectiveness of Leveraging Social Determinants of Health to Improve Breast, Cervical, and Colorectal Cancer Screening: A Systematic Review.
    JAMA Oncol. 2020;6:1434-1444.
    PubMed    
    Abstract available

  162. HARDY LE, Baxter L, Wan K, Ayres C, et al
    Invasive cervical adenocarcinoma arising from extension of recurrent vulval Paget's disease.
    BMJ Case Rep. 2020;13.
    PubMed    
    Abstract available

  163. METAXAS G, Tsiambas E, Kavantzas N, Stavraka C, et al
    Impact of Cyclin D1 deregulation in HPV-mediated squamous intraepithelial lesions based on cell spots analysis.
    J BUON. 2020;25:792-796.
    PubMed    
    Abstract available

  164. DODD RH, Obermair HM, McCaffery KJ
    Implementing changes to cervical screening: A qualitative study with health professionals.
    Aust N Z J Obstet Gynaecol. 2020;60:776-783.
    PubMed    
    Abstract available

  165. STOLNICU S, Talia KL, McCluggage WG
    The Evolving Spectrum of Precursor Lesions of Cervical Adenocarcinomas.
    Adv Anat Pathol. 2020;27:278-293.
    PubMed    
    Abstract available

  166. SOSSO SM, Tchouaket MCT, Fokam J, Simo RK, et al
    Human immunodeficiency virus is a driven factor of human papilloma virus among women: evidence from a cross-sectional analysis in Yaounde, Cameroon.
    Virol J. 2020;17:69.
    PubMed    
    Abstract available

  167. BARCHITTA M, Maugeri A, La Mastra C, Rosa MC, et al
    Dietary Antioxidant Intake and Human Papillomavirus Infection: Evidence from a Cross-Sectional Study in Italy.
    Nutrients. 2020;12.
    PubMed    
    Abstract available

  168. WANG M, Perucho JAU, Tse KY, Chu MMY, et al
    MRI texture features differentiate clinicopathological characteristics of cervical carcinoma.
    Eur Radiol. 2020;30:5384-5391.
    PubMed    
    Abstract available

  169. PARASKEVAIDIS E, Athanasiou A, Paraskevaidi M, Bilirakis E, et al
    Cervical Pathology Following HPV Vaccination in Greece: A 10-year HeCPA Observational Cohort Study.
    In Vivo. 2020;34:1445-1449.
    PubMed    
    Abstract available

  170. DING H, Xiong XX, Fan GL, Yi YX, et al
    The New Biomarker for Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma (CESC) Based on Public Database Mining.
    Biomed Res Int. 2020;2020:5478574.
    PubMed    
    Abstract available

  171. WANG X, De Geyter C, Jia Z, Peng Y, et al
    HECTD1 regulates the expression of SNAIL: Implications for epithelialmesenchymal transition.
    Int J Oncol. 2020;56:1186-1198.
    PubMed    
    Abstract available

  172. BABA S, Taguchi A, Kawata A, Hara K, et al
    Differential expression of human papillomavirus 16-, 18-, 52-, and 58-derived transcripts in cervical intraepithelial neoplasia.
    Virol J. 2020;17:32.
    PubMed    
    Abstract available

  173. MIAO H, Song WB, Zhu H, Wang Q, et al
    Effect of GREM 1 gene on chemoradiotherapy sensitivity of cervical squamous carcinoma cells.
    Eur Rev Med Pharmacol Sci. 2020;24:1072-1080.
    PubMed    
    Abstract available

  174. VAN BERGEN JEAM
    [HPV vaccination with quadrivalent or nonavalent vaccine: an opportunity to eliminate genital warts as well].
    Ned Tijdschr Geneeskd. 2020;164.
    PubMed    
    Abstract available

  175. POSTMA MJ, Wilschut JC
    [Continue to use the bivalent HPV vaccine; bivalent vaccine more effective than expected].
    Ned Tijdschr Geneeskd. 2020;164.
    PubMed    
    Abstract available

  176. SALLANS RK
    Six Tips for Giving Good Health Care to Anyone With a Cervix.
    AMA J Ethics. 2020;22:E168-175.
    PubMed    
    Abstract available

  177. NDEBELE P, Ruzario S
    How Should Vaccine Campaigns Balance Need for Clear Communication Against Need for Timely Administration of Large-Scale Programs?
    AMA J Ethics. 2020;22:E76-81.
    PubMed    
    Abstract available

  178. RICCI C, Scaldaferri F, Colombo F, Armuzzi A, et al
    Prevalence of cervical HPV and attitude towards cervical screening in IBD patients under immunomodulatory treatment: a multidisciplinary management experience.
    Eur Rev Med Pharmacol Sci. 2020;24:564-570.
    PubMed    
    Abstract available

  179. XIE B, Wan J, Chen X, Han W, et al
    Preclinical Evaluation of a Cabazitaxel Prodrug Using Nanoparticle Delivery for the Treatment of Taxane-Resistant Malignancies.
    Mol Cancer Ther. 2020;19:822-834.
    PubMed    
    Abstract available

  180. MAHUMUD RA, Gow J, Alam K, Keramat SA, et al
    Cost-effectiveness of the introduction of two-dose bi-valent (Cervarix) and quadrivalent (Gardasil) HPV vaccination for adolescent girls in Bangladesh.
    Vaccine. 2019 Oct 24. pii: S0264-410X(19)31410.
    PubMed    
    Abstract available

  181. SAADEH K, Park I, Gargano JW, Whitney E, et al
    Prevalence of human papillomavirus (HPV)-vaccine types by race/ethnicity and sociodemographic factors in women with high-grade cervical intraepithelial neoplasia (CIN2/3/AIS), Alameda County, California, United States.
    Vaccine. 2019 Oct 11. pii: S0264-410X(19)31347.
    PubMed    
    Abstract available

  182. PIYATHILAKE CJ, Badiga S, Burkholder GA, Harada S, et al
    The accuracy of HPV genotyping in isolation and in combination with CD4 and HIV viral load for the identification of HIV-infected women at risk for developing cervical cancer.
    Cancer Med. 2021 Feb 19. doi: 10.1002/cam4.3785.
    PubMed    
    Abstract available

  183. CHAO X, Song X, Wu H, You Y, et al
    Selection of Treatment Regimens for Recurrent Cervical Cancer.
    Front Oncol. 2021;11:618485.
    PubMed    
    Abstract available

  184. CHEN H, Chi Y, Chen M, Zhao L, et al
    Long Intergenic Non-Coding RNA LINC00885 Promotes Tumorigenesis of Cervical Cancer by Upregulating MACC1 Expression Through Serving as a Competitive Endogenous RNA for microRNA-432-5p.
    Cancer Manag Res. 2021;13:1435-1447.
    PubMed    
    Abstract available

  185. CHEN W, Wang B, Zeng R, Wang T, et al
    Development and Validation of a Nomogram for the Estimation of Response to Platinum-Based Neoadjuvant Chemotherapy in Patients with Locally Advanced Cervical Cancer.
    Cancer Manag Res. 2021;13:1279-1289.
    PubMed    
    Abstract available

  186. ZHAO W, Yang Q
    Lymph-Vascular Space Invasion in Patients with Stages IA2-IIA2 Cervical Cancer Treated with Laparoscopic versus Open Radical Hysterectomy.
    Cancer Manag Res. 2021;13:1179-1186.
    PubMed    
    Abstract available

  187. HU J, Wang R, Liu Y, Zhou J, et al
    Baicalein Represses Cervical Cancer Cell Growth, Cell Cycle Progression and Promotes Apoptosis via Blocking AKT/mTOR Pathway by the Regulation of circHIAT1/miR-19a-3p Axis.
    Onco Targets Ther. 2021;14:905-916.
    PubMed    
    Abstract available

  188. YE H, Chu X, Cao Z, Hu X, et al
    A Novel Targeted Therapy System for Cervical Cancer: Co-Delivery System of Antisense LncRNA of MDC1 and Oxaliplatin Magnetic Thermosensitive Cationic Liposome Drug Carrier.
    Int J Nanomedicine. 2021;16:1051-1066.
    PubMed    
    Abstract available

  189. HAO Y, Ye M, Chen X, Zhao H, et al
    Discovery and validation of FBLN1 and ANT3 as potential biomarkers for early detection of cervical cancer.
    Cancer Cell Int. 2021;21:125.
    PubMed    
    Abstract available

  190. ADEDIMEJI A, Ajeh R, Pierz A, Nkeng R, et al
    Challenges and opportunities associated with cervical cancer screening programs in a low income, high HIV prevalence context.
    BMC Womens Health. 2021;21:74.
    PubMed    
    Abstract available

  191. VASH-MARGITA A, Kobernik EK, Flagler E, Quint EH, et al
    National Trends in Cervical Cancer Screening in Adolescents.
    J Pediatr Adolesc Gynecol. 2021 Feb 15. pii: S1083-3188(21)00121.
    PubMed    
    Abstract available

  192. WU Y, Chen X, Dong W, Xu Z, et al
    ST3Gal IV Mediates the Growth and Proliferation of Cervical Cancer Cells In Vitro and In Vivo Via the Notch/p21/CDKs Pathway.
    Front Oncol. 2021;10:540332.
    PubMed    
    Abstract available

  193. LIU Q, Wang M, Gayam V, Li XL, et al
    The clinical course and management of cervical cancer with splenic metastasis: Case report and review of the literature.
    Clin Case Rep. 2020;9:689-693.
    PubMed    
    Abstract available

  194. CHEN Y, Chen D, Wang J, Zhang Y, et al
    Dysregulated LncRNAs Act as Competitive Endogenous RNAs and Are Associated With Cervical Cancer Development in UYGHUR Women.
    Technol Cancer Res Treat. 2021;20:1533033821989711.
    PubMed    
    Abstract available

  195. WU N, Su X, Song H, Li Y, et al
    A Multi-Institutional Retrospective Analysis of Oncologic Outcomes for Patients With Locally Advanced Cervical Cancer Undergoing Platinum-Based Adjuvant Chemotherapy After Concurrent Chemoradiotherapy.
    Cancer Control. 2021;28:1073274821989307.
    PubMed    
    Abstract available

  196. JUN T, Chen W, Hailing C, Ning W, et al
    The novel circular RNA circ-PGAP3 retards cervical cancer growth by regulating the miR-769-5p/p53 axis.
    Hum Cell. 2021 Feb 16. pii: 10.1007/s13577-021-00493.
    PubMed    
    Abstract available

  197. IWATA T, Machida H, Matsuo K, Okugawa K, et al
    The validity of the subsequent pregnancy index score for fertility-sparing trachelectomy in early-stage cervical cancer.
    Fertil Steril. 2021 Feb 12. pii: S0015-0282(20)32404.
    PubMed    
    Abstract available

  198. ZHANG X, Zhang Q, Zhang K, Wang F, et al
    Circ SMARCA5 Inhibited Tumor Metastasis by Interacting with SND1 and Downregulating the YWHAB Gene in Cervical Cancer.
    Cell Transplant. 2021;30:963689720983786.
    PubMed    
    Abstract available


  199. The Impact of Education About Cervical Cancer and Human Papillomavirus on Women's Healthy Lifestyle Behaviors and Beliefs: Using the PRECEDE Educational Model: ERRATUM.
    Cancer Nurs. 2021;44:124.
    PubMed    


  200. HASAN ME, Matin M, Haque ME, Aziz MA, et al
    Polymorphic variants INSIG2 rs6726538, HLA-DRB1 rs9272143, and GCNT1P5 rs7780883 contribute to the susceptibility of cervical cancer in the Bangladeshi women.
    Cancer Med. 2021 Feb 14. doi: 10.1002/cam4.3782.
    PubMed    
    Abstract available

  201. HUANG C, Chen Z, He Y, He Z, et al
    EphA2 promotes tumorigenicity of cervical cancer by up-regulating CDK6.
    J Cell Mol Med. 2021 Feb 14. doi: 10.1111/jcmm.16337.
    PubMed    
    Abstract available

  202. SONG J, Hu Q, Ma Z, Zhao M, et al
    Feasibility of T2WI-MRI-based radiomics nomogram for predicting normal-sized pelvic lymph node metastasis in cervical cancer patients.
    Eur Radiol. 2021 Feb 14. pii: 10.1007/s00330-021-07735.
    PubMed    
    Abstract available

  203. KE L, Chen Y, Li Y, Chen Z, et al
    miR-142-5p promotes cervical cancer progression by targeting LMX1A through Wnt/beta-catenin pathway.
    Open Med (Wars). 2021;16:224-236.
    PubMed    
    Abstract available

  204. LIAO W, He J, Disoma C, Hu Y, et al
    Hsa_circ_0107593 Suppresses the Progression of Cervical Cancer via Sponging hsa-miR-20a-5p/93-5p/106b-5p.
    Front Oncol. 2021;10:590627.
    PubMed    
    Abstract available

  205. KUROSAKI H, Utsumi N, Miura K
    Radiotherapy Planning System to Measure Tumor Doubling Time in Cervical Cancer.
    Cureus. 2021;13:e12612.
    PubMed    
    Abstract available

  206. LIN AJ, Dehdashti F, Massad LS, Thaker PH, et al
    Long-Term Outcomes of Cervical Cancer Patients Treated With Definitive Chemoradiation Following a Complete Metabolic Response.
    Clin Oncol (R Coll Radiol). 2021 Feb 10. pii: S0936-6555(21)00010.
    PubMed    
    Abstract available

  207. LYNCH J, D'Alton P, Gaynor K
    Exploring the psychological impact of the cervical cancer screening failures on women in Ireland: A qualitative study.
    Psychooncology. 2021 Feb 13. doi: 10.1002/pon.5635.
    PubMed    


  208. CHELLAPANDIAN P, Myneni S, Ravikumar D, Padmanaban P, et al
    Knowledge on cervical cancer and perceived barriers to the uptake of HPV vaccination among health professionals.
    BMC Womens Health. 2021;21:65.
    PubMed    
    Abstract available

  209. ISAKA Y, Hori A, Tanaka R, Ichikawa M, et al
    Alleviating psychological distress associated with a positive cervical cancer screening result: a randomized control trial.
    BMC Womens Health. 2021;21:64.
    PubMed    
    Abstract available

  210. TODOR RD, Bratucu G, Moga MA, Candrea AN, et al
    Challenges in the Prevention of Cervical Cancer in Romania.
    Int J Environ Res Public Health. 2021;18.
    PubMed    
    Abstract available

  211. YANG YR, Chen SJ, Yen PY, Huang CP, et al
    Hydronephrosis in patients with cervical cancer is an indicator of poor outcome: A nationwide population-based retrospective cohort study.
    Medicine (Baltimore). 2021;100:e24182.
    PubMed    
    Abstract available

  212. BASU P
    2021: a new year for the WHO.
    Nat Med. 2021;27:1.
    PubMed    


  213. CHEE YC, Abdul Halim S
    Cerebral venous sinus thrombosis in a patient with concomitant Graves' disease and squamous cell carcinoma of the cervix.
    BMJ Case Rep. 2020;13.
    PubMed    
    Abstract available

  214. MA K, Zhao L, Yue Y, Huo F, et al
    Thiol "Click" Chromene Ring Opening and Subsequent Cascade Nucleophilic Cyclization NIR Fluorescence Imaging Reveal High Levels of Thiol in Drug-Resistant Cells.
    Anal Chem. 2020;92:15936-15942.
    PubMed    
    Abstract available

  215. MOMENI R, Hosseini Z, Aghamolaei T, Ghanbarnejad A, et al
    Determinants factors to Pap smear screening among married women in a city of South Iran: applying the BASNEF model.
    BMC Womens Health. 2020;20:237.
    PubMed    
    Abstract available

  216. RAMIA DE CAP M, Jou D, Chen Y, Hecht JL, et al
    Impact of a Modified HistoGel Method for Processing Endocervical Curettage Specimens on Diagnostic Yield.
    Am J Clin Pathol. 2021;155:141-147.
    PubMed    
    Abstract available

  217. MORTON R, Mylvaganam G, Anderson L, Farrell R, et al
    Follow-up after treatment of high-grade cervical dysplasia: The utility of six-month colposcopy and cytology and routine 12-month colposcopy.
    Aust N Z J Obstet Gynaecol. 2020;60:959-964.
    PubMed    
    Abstract available

  218. TAN JHJ, Jayasinghe YL, Osinski MJ, Brotherton JML, et al
    Recurrent post-coital bleeding: Should colposcopy still be mandatory?
    Aust N Z J Obstet Gynaecol. 2020;60:952-958.
    PubMed    
    Abstract available

  219. ALBRIGHT BB, Nasioudis D, Craig S, Moss HA, et al
    Impact of Medicaid expansion on women with gynecologic cancer: A difference-in-difference analysis.
    Am J Obstet Gynecol. 2020 Aug 7. pii: S0002-9378(20)30835.
    PubMed    
    Abstract available

  220. KAZAKOVA V, Moreno Vanegas YA, Kadamkulam Syriac A, Kozyreva O, et al
    Multimodality therapy of endometrial glassy cell carcinoma: a rare type of cancer.
    BMJ Case Rep. 2020;13.
    PubMed    
    Abstract available

  221. MCMELLEN A, Woodruff ER, Corr BR, Bitler BG, et al
    Wnt Signaling in Gynecologic Malignancies.
    Int J Mol Sci. 2020;21.
    PubMed    
    Abstract available

  222. LIN Z, Lin Y, Shen J, Jiang M, et al
    Flavonoids in Ageratum conyzoides L. Exert Potent Antitumor Effects on Human Cervical Adenocarcinoma HeLa Cells In Vitro and In Vivo.
    Biomed Res Int. 2020;2020:2696350.
    PubMed    
    Abstract available

  223. PHAM CT, Juhasz M, Sung CT, Mesinkovska NA, et al
    Reply to: "Comment on 'The human papillomavirus vaccine as a treatment for human papillomavirus-related dysplastic and neoplastic conditions: A literature review'".
    J Am Acad Dermatol. 2020;83:e207.
    PubMed    


  224. MEDEPALLI VM, Liles JE, Davis LS
    Comment on "The human papillomavirus vaccine as a treatment for human papillomavirus-related dysplastic and neoplastic conditions: A literature review".
    J Am Acad Dermatol. 2020;83:e205-e206.
    PubMed    


  225. HUANG J, Diao G, Zhang Q, Chen Y, et al
    E6regulated overproduction of prostaglandin E2 may inhibit migration of dendritic cells in human papillomavirus 16positive cervical lesions.
    Int J Oncol. 2020;56:921-931.
    PubMed    
    Abstract available

  226. ZHENG S, Li R, Liang J, Wen Z, et al
    Serum miR-638 Combined with Squamous Cell Carcinoma-Related Antigen as Potential Screening Biomarkers for Cervical Squamous Cell Carcinoma.
    Genet Test Mol Biomarkers. 2020;24:188-194.
    PubMed    
    Abstract available

  227. HU R, Dong Z, Zhang K, Pan G, et al
    Preparation, Characterization and Diagnostic Valuation of Two Novel Anti-HPV16 E7 Oncoprotein Monoclonal Antibodies.
    Viruses. 2020;12.
    PubMed    
    Abstract available

  228. NAGENDIRAM A, Bidgood R, Banks J, Heal C, et al
    Knowledge and perspectives of the new National Cervical Screening Program: a qualitative interview study of North Queensland women-'I could be that one percent'.
    BMJ Open. 2020;10:e034483.
    PubMed    
    Abstract available

  229. KIM JH, Shim SH, Nam SH, Lee SW, et al
    Prognostic Factors and Impact of Minimally Invasive Surgery in Early-stage Neuroendocrine Carcinoma of the Cervix.
    J Minim Invasive Gynecol. 2020;27:1558-1565.
    PubMed    
    Abstract available

  230. PENG L, Hu C, Zhang C, Lu Y, et al
    Anti-cancer activity of Conyza blinii saponin against cervical carcinoma through MAPK/TGF-beta/Nrf2 signaling pathways.
    J Ethnopharmacol. 2020;251:112503.
    PubMed    
    Abstract available

  231. SCHROER-GUNTHER M, Fechtelpeter D, Zschorlich B, Wegmann M, et al
    [Development of Decision Aids for Organized Cervical Carcinoma Screening in Germany].
    Gesundheitswesen. 2021;83:128-134.
    PubMed    
    Abstract available

  232. SCHWOCK J, Starova B, Khan ZF, Mirkovic J, et al
    Cytomorphologic Features of Gastric-Type Endocervical Adenocarcinoma in Liquid-Based Preparations.
    Acta Cytol. 2021;65:56-66.
    PubMed    
    Abstract available

  233. KUSSAIBI H, Al Dossary R, Ahmed A, Muammar A, et al
    Correlation of High-Risk HPV Genotypes with Pap Test Findings: A Retrospective Study in Eastern Province, Saudi Arabia.
    Acta Cytol. 2021;65:48-55.
    PubMed    
    Abstract available

  234. THOMSEN LT, Kjaer SK, Munk C, Ornskov D, et al
    Benefits and potential harms of human papillomavirus (HPV)-based cervical cancer screening: A real-world comparison of HPV testing versus cytology.
    Acta Obstet Gynecol Scand. 2021 Feb 10. doi: 10.1111/aogs.14121.
    PubMed    
    Abstract available

  235. TEGUETE I, Tounkara FK, Diawara B, Traore S, et al
    A population-based combination strategy to improve the cervical cancer screening coverage rate in Bamako, Mali.
    Acta Obstet Gynecol Scand. 2021 Feb 9. doi: 10.1111/aogs.14119.
    PubMed    
    Abstract available

  236. CASTANON A, Rebolj M, Pesola F, Sasieni P, et al
    Recovery strategies following COVID-19 disruption to cervical cancer screening and their impact on excess diagnoses.
    Br J Cancer. 2021 Feb 9. pii: 10.1038/s41416-021-01275.
    PubMed    
    Abstract available

  237. LEI J, Ploner A, Lehtinen M, Sparen P, et al
    Impact of HPV vaccination on cervical screening performance: a population-based cohort study.
    Br J Cancer. 2020 May 4. pii: 10.1038/s41416-020-0850.
    PubMed    
    Abstract available

  238. KHELIL M, Griffin H, Bleeker MCG, Steenbergen RDM, et al
    Delta-like ligand-Notch1 signalling is selectively modulated by HPV16 E6 to promote squamous cell proliferation and correlates with cervical cancer prognosis.
    Cancer Res. 2021 Jan 26. pii: 0008-5472.CAN-20-1996.
    PubMed    
    Abstract available

  239. REZENDE MT, Bianchi AGC, Carneiro CM
    Cervical cancer: Automation of Pap test screening.
    Diagn Cytopathol. 2021 Feb 6. doi: 10.1002/dc.24708.
    PubMed    
    Abstract available

  240. SHEN F, Sun SG, Zhang XY, Wang Q, et al
    Clinical outcomes of vaginectomy and laser ablation for the treatment of post-hysterectomy women with vaginal high-grade squamous intraepithelial lesions: A retrospective study.
    Eur J Obstet Gynecol Reprod Biol. 2020;248:71-76.
    PubMed    
    Abstract available

  241. BJORNEREM MS, Sorbye SW, Skjeldestad FE
    Recurrent disease after treatment for cervical intraepithelial neoplasia-The importance of a flawless definition of residual disease and length of follow-up.
    Eur J Obstet Gynecol Reprod Biol. 2020;248:44-49.
    PubMed    
    Abstract available

  242. VARELA CAGETTI L, Gonzague-Casabianca L, Zemmour C, Lambaudie E, et al
    The impact of modern preoperative high-dose-rate brachytherapy in early-stage cervical cancer.
    Gynecol Oncol. 2021 Feb 6. pii: S0090-8258(21)00094.
    PubMed    
    Abstract available

  243. GULTEKIN M, Dundar S, Keskinkilic B, Turkyilmaz M, et al
    How to triage HPV positive cases: Results of four million females.
    Gynecol Oncol. 2020 Apr 30. pii: S0090-8258(20)31008.
    PubMed    
    Abstract available

  244. REICH O, Regauer S, Kashofer K
    Possibly carcinogenic HPV subtypes are a cause of HSIL and negative clinical HPV tests - A European prospective single center study.
    Gynecol Oncol. 2020 Apr 27. pii: S0090-8258(20)30985.
    PubMed    
    Abstract available

  245. HORTLUND M, van Mol T, Van de Pol F, Bogers JP, et al
    Human Papillomavirus Load and Genotype Analysis Improves the Prediction of Invasive Cervical Cancer.
    Int J Cancer. 2021 Feb 14. doi: 10.1002/ijc.33519.
    PubMed    
    Abstract available

  246. TANG X, Qiu J, Guo C, Guo J, et al
    A novel prognostic nomogram utilizing the 2018 FIGO staging system for cervical cancer: A large multicenter study.
    Int J Gynaecol Obstet. 2021 Feb 15. doi: 10.1002/ijgo.13644.
    PubMed    
    Abstract available

  247. RODRIGUEZ J, Rauh-Hain JA, Saenz J, Isla DO, et al
    Oncological outcomes of laparoscopic radical hysterectomy versus radical abdominal hysterectomy in patients with early-stage cervical cancer: a multicenter analysis.
    Int J Gynecol Cancer. 2021 Jan 27. pii: ijgc-2020-002086.
    PubMed    
    Abstract available

  248. SCOTT AA, Yarney J, Vanderpuye V, Akoto Aidoo C, et al
    Outcomes of patients with cervical cancer treated with low- or high-dose rate brachytherapy after concurrent chemoradiation.
    Int J Gynecol Cancer. 2021 Feb 8. pii: ijgc-2020-002120.
    PubMed    
    Abstract available

  249. WANG Y, Chen H
    In Reply to Ghadjar et al.
    Int J Radiat Oncol Biol Phys. 2020;107:856.
    PubMed    


  250. GHADJAR P, Beck M, Zschaeck S, Wust P, et al
    In Regard to Wang et al.
    Int J Radiat Oncol Biol Phys. 2020;107:855.
    PubMed    


  251. MELL LK, Xu R, Yashar CM, McHale MT, et al
    Phase 1 Trial of Concurrent Gemcitabine and Cisplatin with Image-Guided Intensity Modulated Radiation Therapy for Locoregionally Advanced Cervical Carcinoma.
    Int J Radiat Oncol Biol Phys. 2020 Apr 22. pii: S0360-3016(20)31037.
    PubMed    
    Abstract available

  252. MA HR, Cao L, Wang F, Cheng C, et al
    Filamin B extensively regulates transcription and alternative splicing, and is associated with apoptosis in HeLa cells.
    Oncol Rep. 2020;43:1536-1546.
    PubMed    
    Abstract available

  253. SPAMPINATO S, Fokdal LU, Potter R, Haie-Meder C, et al
    Risk factors and dose-effects for bladder fistula, bleeding and cystitis after radiotherapy with imaged-guided adaptive brachytherapy for cervical cancer: an EMBRACE analysis.
    Radiother Oncol. 2021 Feb 2. pii: S0167-8140(21)00020.
    PubMed    
    Abstract available

  254. AARNIO R, Ostensson E, Olovsson M, Gustavsson I, et al
    Cost-effectiveness analysis of repeated self-sampling for HPV testing in primary cervical screening: a randomized study.
    BMC Cancer. 2020;20:645.
    PubMed    
    Abstract available

  255. OBOL JH, Lin S, Obwolo MJ, Harrison R, et al
    Knowledge, attitudes, and practice of cervical cancer prevention among health workers in rural health centres of Northern Uganda.
    BMC Cancer. 2021;21:110.
    PubMed    
    Abstract available

  256. CHI RA, van der Watt P, Wei W, Birrer MJ, et al
    Inhibition of Kpnbeta1 mediated nuclear import enhances cisplatin chemosensitivity in cervical cancer.
    BMC Cancer. 2021;21:106.
    PubMed    
    Abstract available

  257. CHEN P, Jiao L, Ren F, Wang DB, et al
    Clinical value of serum squamous cell carcinoma antigen levels in predicting chemosensitivity, lymph node metastasis, and prognosis in patients with cervical squamous cell carcinoma.
    BMC Cancer. 2020;20:423.
    PubMed    
    Abstract available

  258. EJEGOD DM, Lagheden C, Bhatia R, Pedersen H, et al
    Clinical validation of full genotyping CLART(R) HPV4S assay on SurePath and ThinPrep collected screening samples according to the international guidelines for human papillomavirus test requirements for cervical screening.
    BMC Cancer. 2020;20:396.
    PubMed    
    Abstract available

  259. CHU G, Liu X, Yu W, Chen M, et al
    Cisplatin plus paclitaxel chemotherapy with or without bevacizumab in postmenopausal women with previously untreated advanced cervical cancer: a retrospective study.
    BMC Cancer. 2021;21:133.
    PubMed    
    Abstract available

  260. GOUY S, Seebacher V, Chargari C, Terroir M, et al
    False negative rate at (18)F-FDG PET/CT in para-aortic lymphnode involvement in patients with locally advanced cervical cancer: impact of PET technology.
    BMC Cancer. 2021;21:135.
    PubMed    
    Abstract available

  261. TESFAW G, Ahmed Y, Gedefaw L, Dube L, et al
    Liquid-based cytology for the detection of cervical intraepithelial lesions in Jimma town, Ethiopia.
    BMC Cancer. 2020;20:706.
    PubMed    
    Abstract available

  262. LEE SY, Chae DK, Lee SH, Lim Y, et al
    Efficient mutation screening for cervical cancers from circulating tumor DNA in blood.
    BMC Cancer. 2020;20:694.
    PubMed    
    Abstract available

  263. CHISALE MABOTJA M, Levin J, Kawonga M
    Beliefs and perceptions regarding cervical cancer and screening associated with Pap smear uptake in Johannesburg: A cross-sectional study.
    PLoS One. 2021;16:e0246574.
    PubMed    
    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design:


;